StockData
Illumina, Inc. logo

Illumina, Inc. (ILMN) company profile

ILMNNasdaqLaboratory Analytical InstrumentsFiscal year ends January 3
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 27, 2026Last filing: 10-Q on Oct 30, 2026Score 14/309% above fair value
$202.61+4.61 (+2.33%)

Close on Nov 17, 2026Market cap $30.63BP/E 34.8Yield –

About Illumina

Laboratory Analytical Instruments, SIC 3826

Illumina, Inc. develops and provides genetic analysis solutions, focusing on sequencing- and microarray-based technologies. The company supplies integrated platforms, specialized instruments, and consumable reagents that enable researchers and healthcare specialists to analyze genetic variation and biological function. Its offerings support a broad range of life science applications, including clinical diagnostics, oncology, reproductive health, and genomics research. Customers primarily include academic and research institutions, clinical laboratories, pharmaceutical and biotechnology companies, and genomic centers.

The company operates globally across several major geographic regions, including the Americas, Europe, China, and the Asia-Pacific, Middle East, and Africa regions. In addition to its domestic presence in the United States, it conducts international business and maintains accounts and operations in jurisdictions such as Singapore and the United Kingdom. Illumina maintains its principal executive headquarters in San Diego, California.

Summary of the business section of Illumina's latest annual report, written by StockData.

Company profile

Company

Legal name
Illumina, Inc.
Founded
1998
Headquarters
San Diego, CA
Address
5200 Illumina Way 92122
Phone
(858) 202-4500
Employees
52, Dec 31, 2023
Industry
Laboratory Analytical Instruments
Incorporated in
Delaware
Fiscal year ends
January 3
Auditor
Ernst & Young LLP, SanDiego, California

Stock & identifiers

Ticker
ILMN
Exchange
Nasdaq
IPO date
Jul 28, 2000
Shares outstanding
151M, Oct 23, 2026
Public float
$9.20B, Jun 29, 2025
Filer category
Large accelerated filer
Stock splits
2-for-1, Sep 23, 2008
SEC CIK
1110803
CUSIP
452327109
ISIN
US4523271090
FIGI
BBG000DSMS70
Share class FIGI
BBG001SF4NY1
LEI
SQ95QG8SR5Q56LSNF682
EIN
33-0804655

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Jacob ThaysenChief Executive Officer, Director107,770
Scott D. EricksenVP, Chief Accounting Officer14,029
Patricia LeckmanSVP, Chief People Officer21,120
Kevin Carl PegelsChief of Global Operations28,434
Steven BarnardSVP, Chief Technology Officer40,567
Julie Ann ColettiChief Legal Officer18,763
Christensen Jakob WedelSVP, Strategy/Corp Development14,023
Michael C. SullivanChief Commercial Officer4,503
Scott M. DaviesChief Legal Officer20,338
Ankur DhingraSVP, Chief Financial Officer34,264
Everett CunninghamSVP, Chief Commercial Officer46,592
Carissa RollinsSVP, Chief Information Officer18,447
Keith A. MeisterDirector215,713
Scott B. UllemDirector11,143
Daniel SkovronskyDirector1,674
Caroline DorsaDirector15,754
Scott GottliebDirector14,795
Philip W. SchillerDirector22,220
David P. KingDirector2,072
Anna RichoDirector8,527
Susan E. SiegelDirector20,541
Robert S. EpsteinDirector22,139
Frances ArnoldDirector20,907
Gary S. GuthartDirector16,430

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Charles Dadswell
$0$0$3.71M$36$122
FY2025
Francis Desouza
$0$0$3.71M$36$122
FY2025
Jacob Thaysen
$11.02M$12.83M$3.71M$36$122
FY2024
Charles Dadswell
$0$0$5.43M$37$92
FY2024
Francis Desouza
$0$0$5.43M$37$92
FY2024
Jacob Thaysen
$14.80M$17.69M$5.43M$37$92

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsIncentive payOtherTotalvs. prior year
Jacob Thaysen
Chief Executive Officer
$1.00M–$8.76M$1.16M$100.77K$11.02M-26%
Ankur Dhingra
Chief Financial Officer
$650.00K–$3.09M$325.33K$10.67K$4.08M-30%
Steve Barnard
Chief Technology Officer
$600.00K–$2.56M$300.30K$17.68K$3.48M-13%
Kevin Pegels
Chief of Global Operations
$575.00K–$2.30M$287.79K$20.20K$3.18M-17%
Everett Cunningham
Former Chief Commercial Officer
$650.00K$500.00K$2.87M–$65.88K$4.09M-59%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“The modifications affected 52 employees with units granted in 2019, which resulted in total incremental share-based compensation cost of approximately $ 41 million, and 72 employees with units granted in 2020, which resulted in total incremental share-based compensation cost of approximately $ 65 million.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?